Anti-inflammatory drug nanocrystals: state of art and regulatory perspective (2021)
Source: European Journal of Pharmaceutical Sciences. Unidade: FCF
Subjects: ANTI-INFLAMATÓRIOS NÃO ESTEROIDES, NANOTECNOLOGIA
ABNT
MACEDO, Luiza Oliveira et al. Anti-inflammatory drug nanocrystals: state of art and regulatory perspective. European Journal of Pharmaceutical Sciences, v. 158, p. 1-15 art. 105654, 2021Tradução . . Disponível em: https://doi.org/10.1016/j.ejps.2020.105654. Acesso em: 04 jun. 2024.APA
Macedo, L. O., Barbosa, E. J., Löbenberg, R., & Bou-Chacra, N. A. (2021). Anti-inflammatory drug nanocrystals: state of art and regulatory perspective. European Journal of Pharmaceutical Sciences, 158, 1-15 art. 105654. doi:10.1016/j.ejps.2020.105654NLM
Macedo LO, Barbosa EJ, Löbenberg R, Bou-Chacra NA. Anti-inflammatory drug nanocrystals: state of art and regulatory perspective [Internet]. European Journal of Pharmaceutical Sciences. 2021 ; 158 1-15 art. 105654.[citado 2024 jun. 04 ] Available from: https://doi.org/10.1016/j.ejps.2020.105654Vancouver
Macedo LO, Barbosa EJ, Löbenberg R, Bou-Chacra NA. Anti-inflammatory drug nanocrystals: state of art and regulatory perspective [Internet]. European Journal of Pharmaceutical Sciences. 2021 ; 158 1-15 art. 105654.[citado 2024 jun. 04 ] Available from: https://doi.org/10.1016/j.ejps.2020.105654